Author

Sunil Yadav

Stanford Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Assay:CRISPR screen· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Adam S. HelmsiD· 1 shared Alain Morejon Morales· 1 shared Alexandra K. KiemeriD· 1 shared Anand KrishnaniD· 1 shared Andrew David KrahniD· 1 shared Andrew FreywaldiD· 1 shared Andrew Michael GlazeriD· 1 shared Angie Chen· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Adam S. HelmsORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Damaging RBM20 E-rich domain variants are not rescued by gene replacement

Fang Bai, K.Y. Chua, Daniel Yuhang Li, Anna Kirillova, Sunil Yadav, David Staudt, Yuta Yamamoto, Hannah N. De Jong, Linda Helena Müller, Kai Fenzl, Non Rungaramsin, Yong Huang, Chloe M. Reuter, Steven Zhang, Vikki A. Krysov, , Victoria Nicole Parikh

The paper investigates E-rich domain variants of RBM20, showing they reduce protein abundance and cause splicing defects, but are not rescued by RBM20 overexpression.

bioRxiv · Jul 20, 2026 · PreprintGenetics

Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality

Chelsea E. Cunningham, Frederick S. Vizeacoumar, Yue Zhang, Liliia Kyrylenko, Simon Both, Vincent Maranda, He Dong, Jared D. W. Price, Peng Gao, Konrad Wagner, Yingwen Wu, Mary Lazell-Wright, Ashtalakshmi Ganapathysamy, Rithik Hari, Kalpana Kalyanasundaram Bhanumathy, , Franco J. Vizeacoumar

The paper identifies synthetic dosage lethality targets for PLK1-overexpressing cancers using genome-wide screens and validates key hits to show their therapeutic potential.

Cell Genomics · May 9, 2025Peer-reviewedCancer Biology